Your browser doesn't support javascript.
loading
Left and Right Ventricular Longitudinal Systolic Function Following Aortic Valve Replacement in the PARTNER 2 Trial And Registry.
Silva, Iria; Ternacle, Julien; Hahn, Rebecca T; Salah-Annabi, Mohamed; Dahou, Abdellaziz; Krapf, Laura; Salaun, Erwan; Guzzetti, Ezequiel; Xu, Ke; Clavel, Marie-Annick; Bernier, Mathieu; Beaudoin, Jonathan; Cremer, Paul C; Jaber, Wael; Rodriguez, Leonardo; Asch, Federico M; Weismann, Neil J; Bax, Jeroen; Ajmone, Nina; Alu, Maria C; Kallel, Faouzi; Mack, Michael J; Webb, John G; Kapadia, Samir; Makkar, Raj; Kodali, Susheel; Herrmann, Howard C; Thourani, Vinod; Leon, Martin B; Pibarot, Philippe.
Afiliação
  • Silva I; Department of Cardiology, Québec Heart & Lung Institute, Laval University, Québec, Canada.
  • Ternacle J; Central University Hospital of Asturias, Oviedo, Spain.
  • Hahn RT; Haut-Leveque Cardiology Hospital, Bordeaux University, Pessac, France.
  • Salah-Annabi M; Department of Medicine, Columbia University Medical Center, New York, NY.
  • Dahou A; Department of Cardiology, Hôpital de Papineau, Gatineau, Québec, Canada.
  • Krapf L; St Francis Hospital & Heart Center, New York, NY.
  • Salaun E; Haut-Leveque Cardiology Hospital, Bordeaux University, Pessac, France.
  • Guzzetti E; Department of Cardiology, Québec Heart & Lung Institute, Laval University, Québec, Canada.
  • Xu K; Centre Hospitalier Affilié Universitaire Régional, Trois-Rivières, Québec, Canada.
  • Clavel MA; Edwards Lifesciences, Irvine, CA, USA.
  • Bernier M; Department of Cardiology, Québec Heart & Lung Institute, Laval University, Québec, Canada.
  • Beaudoin J; Department of Cardiology, Québec Heart & Lung Institute, Laval University, Québec, Canada.
  • Cremer PC; Department of Cardiology, Québec Heart & Lung Institute, Laval University, Québec, Canada.
  • Jaber W; Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA.
  • Rodriguez L; Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA.
  • Asch FM; Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA.
  • Weismann NJ; MedStar Heart and Vascular Institute and Georgetown University, Washington, DC, USA.
  • Bax J; MedStar Heart and Vascular Institute and Georgetown University, Washington, DC, USA.
  • Ajmone N; Hart Long Centrum Leiden. Leiden University, Netherlands.
  • Alu MC; Hart Long Centrum Leiden. Leiden University, Netherlands.
  • Kallel F; Cardiovascular research Foundation, New York, NY, USA.
  • Mack MJ; Edwards Lifesciences, Irvine, CA, USA.
  • Webb JG; Baylor Scott & White Health System, Plano, TX.
  • Kapadia S; Centre for Cardiovascular Innovation, St Paul's and Vancouver General Hospital, Vancouver, Canada.
  • Makkar R; Department of Cardiology, Cleveland Clinic, Cleveland, OH, USA.
  • Kodali S; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Herrmann HC; Department of Medicine, Columbia University Medical Center, New York, NY.
  • Thourani V; University of Pennsylvania, Philadelphia, PA, USA.
  • Leon MB; Department of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute, Atlanta, GA, USA.
  • Pibarot P; Department of Medicine, Columbia University Medical Center, New York, NY.
Article em En | MEDLINE | ID: mdl-38693866
ABSTRACT

AIMS:

Evaluation of left and right ventricular longitudinal systolic function may enhance risk stratification following aortic valve replacement (AVR). The study objective was to evaluate the changes in left and right ventricular longitudinal systolic function and RV-pulmonary artery (RV-PA) coupling from baseline to 30-days and 1-year after aortic valve replacement (AVR). METHODS AND

RESULTS:

LV longitudinal strain (LS), tricuspid annulus plane systolic excursion (TAPSE), and RV-PA coupling were evaluated in patients from the PARTNER-2A surgical AVR (SAVR) arm (n=985) and from the PARTNER-2 SAPIEN-3 registry (n=719). TAPSE and RV-PA coupling decreased significantly following SAVR, but remained stable following TAVR. Lower LV LS, TAPSE, or RV-PA coupling at baseline were associated with increased risk of the composite of death, hospitalization, and stroke at 5-years (Adjusted-HRs for LV LS<15% 1.24 95%CI 1.05-1.45, p=0.001; TAPSE<14mm 1.44 95%CI 1.21-1.73, p<0.001; RV/PA coupling<0.55mm/mmHg 1.32 95% CI 1.07-1.63, p=0.011). Reduced TAPSE at baseline was the most powerful predictor of the composite endpoint at 5-years. Patients with LV ejection fraction <50% at baseline had increased risk of the primary endpoint with SAVR (HR 1.34, 95%CI 1.08-1.68, p=0.009) but not with TAVR (HR 1.12, 95%CI 0.88-1.42). Lower RV-PA coupling at 30-days showed the strongest association with cardiac mortality.

CONCLUSION:

SAVR but not TAVR was associated with a marked deterioration in RV longitudinal systolic function and RV-PA coupling. Lower TAPSE and RV-PA coupling at 30-days were associated with inferior clinical outcomes at 5-years. In patients with LVEF<50%, TAVR was associated with superior 5-year outcomes.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Heart J Cardiovasc Imaging Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Eur Heart J Cardiovasc Imaging Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá
...